Clinical Trials
5 trialsNCT03874858 2026-04-02
DANTE
Novartis
Phase 2 Completed
NCT02467270 2026-03-17
OPTIC
Takeda
Phase 2 Completed
NCT07374120 2026-02-02
Treatment Patterns and Key Endpoints Among Patients With Chronic-Phase Chronic Myeloid Leukemia in a Community Oncology Setting
Novartis
Completed
NCT00254423 2026-01-15
Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center
Phase 2 Completed
NCT04666259 2025-10-16
AIM4CML
Novartis
Phase 3 Completed